Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: A review of the literature

Journal of Clinical Psychiatry

Volumn 75, Issue 10, 2014, Pages e1142-e1152

  Suri, Rita ^a   Lin, Alex S ^a   Cohen, Lee S ^b   Altshuler, Lori L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

AUTONOMIC NERVOUS SYSTEM FUNCTION; BRAIN DEVELOPMENT; CHILD; CHILD BEHAVIOR; COGNITION; DELIVERY; DISTRESS SYNDROME; FEMALE; HABITUATION; HUMAN; INFANT; LANGUAGE DEVELOPMENT; MATERNAL STRESS; MOTOR ACTIVITY; NERVE CELL DIFFERENTIATION; NONHUMAN; ORIENTATION; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REVIEW; SLEEP; SOCIAL BEHAVIOR; SYMPTOMATOLOGY; DEPRESSIVE DISORDER; DRUG EFFECTS; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PSYCHOLOGY;

ANTIDEPRESSIVE AGENTS; CHILD; CHILD BEHAVIOR; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84922393896     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.13r08926     Document Type: Review

References (65)

1. Zuckerman B, Amaro H, Bauchner H, et al. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol. 1989;160(5, pt 1):1107-1111. doi:10.1016/02-9378(89)90170-1 PubMed
2. Ahluwalia IB, Mack KA, Mokdad A. Mental and physical distress and highrisk behaviors among reproductive-age women. Obstet Gynecol. 2004;104(3):477-483. doi:10.1097/01.AOG.0137920.58741.26 PubMed
3. Newport DJ, Ji S, Long Q, et al. Maternal depression and anxiety differentially impact fetal exposures during pregnancy. J Clin Psychiatry. 2012;73(2):247-251. doi:10.408/JCP.10m06783 PubMed
4. Suri R, Altshuler LA, Mintz J. Depression and the decision to abort. Am J Psychiatry. 2004;161(8):1502. doi:10.176/api.ajp.161.8.1502 PubMed
5. Spinelli MG, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am J Psychiatry. 2003;160(3):555-562. doi:10.176/api.ajp.160.3.5 PubMed
6. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2009;114(3):703-713. doi:10.1097/AOG.0b013e3181ba0632 PubMed
7. Loughhead AM, Stowe ZN, Newport DJ, et al. Placental passage of tricyclic antidepressants. Biol Psychiatry. 2006;59(3):287-290. doi:10.1016/j.biopsych.205.06.040 PubMed
8. Wisner KL, Sit DK, Hanusa BH, et al. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry. 2009;166(5):557-566. doi:10.176/api.ajp.208.0808170 PubMed
9. Grote NK, Bridge JA, Gavin AR, et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012-1024. doi:10.101/archgenpsychiatry.2010.1 PubMed
10. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31(5):403-413. doi:10.1016/j.genhospsych.209.04.03 PubMed
11. Wisner KL, Bogen DL, Sit D, et al. Does fetal exposure to SSRIs or maternal depression impact infant growth? Am J Psychiatry. 2013;170(5):485-493. doi:10.176/api.ajp.2012.121873 PubMed
12. Weinstock M. The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev. 2008;32(6):1073-1086. doi:10.1016/j.neubiorev.208.03.02 PubMed
13. Oberlander TF, Gingrich JA, Ansorge MS. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther. 2009;86(6):672-677. doi:10.1038/clpt.209.201 PubMed
14. Field T, Diego MA, Dieter J, et al. Depressed withdrawn and intrusive mothers' effects on their fetuses and neonates. Infant Behav Dev. 2001;24(1):27-39. doi:10.1016/S0163-6383(01)06-2
15. Field T, Diego M, Hernandez-Reif M, et al. Sleep disturbances in depressed pregnant women and their newborns. Infant Behav Dev. 2007;30(1):127-133. doi:10.1016/j.infbeh.206.08.02 PubMed
16. Lundy BL, Jones NA, Field T, et al. Prenatal depression effects on neonates. Infant Behav Dev. 1999;22(1):119-129. doi:10.1016/S0163-6383(9)809-5
17. Marcus S, Lopez JF, McDonough S, et al. Depressive symptoms during pregnancy: impact on neuroendocrine and neonatal outcomes. Infant Behav Dev. 2011;34(1):26-34. doi:10.1016/j.infbeh.2010.07.02 PubMed
18. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSMIV, Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
19. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.17/01462167010306
20. O'Hara M, Varner M, Johnson S. Assessing stressful life events associated with childbearing: the Peripartum Events Scale. J Reprod Infant Psychol. 1986;4(1-2):85-98. doi:10.1080/0264683860840868
21. Brazelton TB. Neonatal Behavior Assessment Scale. Philadelphia, PA: Lippincott; 1984.
22. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561-571. doi:10.101/archpsyc.1961.017101203104 PubMed
23. Lester BM, Tronick EZ. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics. 2004;113(3, pt 2):634-640. PubMed
24. DiPietro JA, Novak MF, Costigan KA, et al. Maternal psychological distress during pregnancy in relation to child development at age two. Child Dev. 2006;77(3):573-587. doi:10.1/j.1467-8624.206.0891.x PubMed
25. Hay DF, Pawlby S, Waters CS, et al. Mothers' antenatal depression and their children's antisocial outcomes. Child Dev. 2010;81(1):149-165. doi:10.1/j.1467-8624.209.01386.x PubMed
26. Tse AC, Rich-Edwards JW, Rifas-Shiman SL, et al. Association of maternal prenatal depressive symptoms with child cognition at age 3 years. Paediatr Perinat Epidemiol. 2010;24(3):232-240. doi:10.1/j.1365-3016.2010.013.x PubMed
27. Nulman I, Koren G, Rovet J, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry. 2012;169(11):1165-1174. doi:10.176/api.ajp.2012.1721 PubMed
28. Weikum WM, Oberlander TF, Hensch TK, et al. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception. Proc Natl Acad Sci U S A. 2012;109(suppl 2):17221-17227. doi:10.1073/pnas.121263109 PubMed
29. Pearson RM, Evans J, Kounali D, et al. Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry. 2013;70(12):1312-1319. doi:10.101/jamapsychiatry.2013.2163 PubMed
30. Bayley N. The Bayley Scales of Infant Development-II. San Antonio, TX: The Psychological Corporation; 1993.
31. Wechsler D. Wechsler Preschool and Primary Scale of Intelligence, 3rd ed (WPPSI-III). San Antonio, TX: Harcourt Assessment; 2002.
32. Angold A, Costello EJ. A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). Psychol Med. 1995;25(4):755-762. doi:10.1017/S03291703491 PubMed
33. Angold A, Prendergast M, Cox A, et al. The Child and Adolescent Psychiatric Assessment (CAPA). Psychol Med. 1995;25(4):739-753. doi:10.1017/S03291703498X PubMed
34. Lewis G, Pelosi AJ, Araya R, et al. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med. 1992;22(2):465-486. doi:10.1017/S032917030415 PubMed
35. Goldberg DP, Cooper B, Eastwood MR, et al. A standardized psychiatric interview for use in community surveys. Br J Prev Soc Med. 1970;24(1):18-23. PubMed
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
37. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150(6):782-786. doi:10.192/bjp.150.6.782 PubMed
38. McNair D, Lorr M, Droppleman L. Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
39. Rampono J, Simmer K, Ilett KF, et al. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry. 2009;42(3):95-100. doi:10.105/s-028-103296 PubMed
40. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113(2):368-375. doi:10.1542/peds.13.2.368 PubMed
41. ter Horst PG, van der Linde S, Smit JP, et al. Clomipramine concentration and withdrawal symptoms in 10 neonates. Br J Clin Pharmacol. 2012;73(2):295-302. doi:10.1/j.1365-2125.201.04072.x PubMed
42. Levinson-Castiel R, Merlob P, Linder N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173-176. doi:10.101/archpedi.160.2.173 PubMed
43. Laine K, Heikkinen T, Ekblad U, et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60(7):720-726. doi:10.101/archpsyc.60.7.720 PubMed
44. Finnegan LP, Connaughton JF Jr, Kron RE, et al. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975;2(1-2):141-158. PubMed
45. Finnegan LP. Neonatal Abstinence Syndrome. In: Nelson NM, ed. Current Therapy in Neonatal-Perinatal Medicine-2. Ontario, BC: Decker, Inc; 1990:314-320.
46. Hendrick V, Stowe ZN, Altshuler LL, et al. Placental passage of antidepressant medications. Am J Psychiatry. 2003;160(5):993-996. doi:10.176/api.ajp.160.5.93 PubMed
47. Oberlander TF, Papsdorf M, Brain UM, et al. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med. 2010;164(5):444-451. doi:10.101/archpediatrics.2010.51 PubMed
48. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 1997;336(4):258-262. doi:10.1056/NEJM197012360404 PubMed
49. Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002;159(11):1889-1895. doi:10.176/api.ajp.159.1.189 PubMed
50. Suri R, Hellemann G, Stowe ZN, et al. A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry. 2011;72(7):1002-1007. doi:10.408/JCP.10m06135 PubMed
51. Casper RC, Gilles AA, Fleisher BE, et al. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology (Berl). 2011;217(2):211-219. doi:10.107/s0213-01-270-z PubMed
52. Casper RC, Fleisher BE, Lee-Ancajas JC, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142(4):402-408. doi:10.1067/mpd.203.139 PubMed
53. Reebye PN, Morison SJ, Panikkar H, et al. Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads. Inf Mental Hlth J. 2002;23(4):403-416. doi:10.102/imhj.1025
54. Oberlander TF, Reebye P, Misri S, et al. Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med. 2007;161(1):22-29. doi:10.101/archpedi.161.1.2 PubMed
55. Misri S, Reebye P, Kendrick K, et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163(6):1026-1032. doi:10.176/api.ajp.163.6.1026 PubMed
56. Weikum WM, Mayes LC, Grunau RE, et al. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age. Infant Behav Dev. 2013;36(4):485-493. doi:10.1016/j.infbeh.2013.04.01 PubMed
57. Oberlander TF, Misri S, Fitzgerald CE, et al. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry. 2004;65(2):230-237. doi:10.408/JCP.v65n0214 PubMed
58. Johnson KC, LaPrairie JL, Brennan PA, et al. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69(8):787-794. doi:10.101/archgenpsychiatry.2012.160 PubMed
59. McCarthy D. McCarthy Scales of Children's Abilities. New York, NY: Psychological Corporation; 1972.
60. Reynell JK. The Reynell Developmental Language Scales (Revised). Windsor, England: National Foundation for Educational Research; 1977.
61. Reynell JK. Reynell Developmental Language Scales Manual. 2nd rev. Windsor England: England NFER-NELSON Publishing; 1985.
62. Ellison PH, Horn JL, Browning CA. Construction of an Infant Neurological International Battery (INFANIB) for the assessment of neurological integrity in infancy. Phys Ther. 1985;65(9):1326-1331. PubMed
63. Clark R. The Parent-Child Early Relational Assessment. Madison, WI: Department of Psychiatry, University of Wisconsin Medical School; 1985.
64. Crowell JA, Feldman SS. Mothers' internal models of relationships and children's behavioral and developmental status: a study of mother-child interaction. Child Dev. 1988;59(5):1273-1285. doi:10.2307/130490 PubMed
65. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005;293(19):2372-2383.